Michael Narachi, CEO & President, Director at Orexigen, holds 26.95K shares in Ultragenyx Pharmaceutical (Ticker: RARE), holds 60.51K shares in Orexigen (Ticker: OREXQ), holds 62.50K shares in Eiger Biopharmaceuticals (Ticker: EIGRQ).
What is the percentage of profitable transactions made by Michael Narachi?
The percentage of profitable transactions made by Michael Narachi is ―.
What is the average return per transaction made by Michael Narachi?
The average return per transaction made by Michael Narachi is ―.
What stocks does Michael Narachi hold?
Michael Narachi holds: OREXQ, EIGRQ, RARE, AMAG stocks.
What was Michael Narachi’s latest transaction?
Michael Narachi latest transaction was an Uninformative Buy of ―.
What was Michael Narachi's most profitable transaction?
Michael Narachi’s most profitable transaction was an Informative Buy of EIGRQ stock on February 6, 2014. The return on the trade was 103.10%.
What is Michael Narachi's role in Orexigen?
Michael Narachi's role in Orexigen is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.